11.18 CAD

Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 6:15:32 AM)
Exchange closed, opens in 2 days 3 hours
-1.84 CAD (-1.84%)
-5.65 CAD (-5.65%)
-2.78 CAD (-2.78%)
28.36 CAD (28.36%)
19.32 CAD (19.32%)
-69.69 CAD (-69.69%)
-93.17 CAD (-93.17%)
-7.88 CAD (-7.88%)

About Bausch Health Cos Inc

Market Capitalization 4.41B

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Headquarters (address)

2150 St. ElzEar Boulevard West

Laval H7L 4A8 QC

Canada

Phone514 744 6792
Websitehttps://www.bauschhealth.com
Employees20,270
SectorHealthcare
IndustryDrug Manufacturers Specialty & Generic
TickerBHC
ExchangeToronto Stock Exchange
CurrencyCAD
52 week range5.45 - 15.43
Market Capitalization4.41B
Dividend yield forward3.39 %
Dividend yield forward Canada (ID:82, base:385) 5.73 %
P/E trailing-7.07
P/E forward1.99
Price/Sale0.465
Price/Book-12.37
Beta0.745
EPS-0.670
EPS Canada (ID:82, base:723) 1.83

Forward Annual Dividend Yield

Forward Annual Dividend Yield: Bausch Health Cos Inc has raised their dividend 3.39 years in a row. This is below the 41189.433000 year average in the 'Drug Manufacturers Specialty & Generic' industry

Forward Annual Dividend Yield

Forward Annual Dividend Yield: Bausch Health Cos Inc has raised their dividend 3.39 years in a row. This is below the 41189.433000 year average in the 'Drug Manufacturers Specialty & Generic' industry

CleverShares.com|
2024 ©

1.0.9092.25789